These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26973244)

  • 61. KIT is a frequent target for epigenetic silencing in cutaneous melanoma.
    Dahl C; Abildgaard C; Riber-Hansen R; Steiniche T; Lade-Keller J; Guldberg P
    J Invest Dermatol; 2015 Feb; 135(2):516-524. PubMed ID: 25178104
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T; Giuliano S; Ye T; Bonet C; Keime C; Kobi D; Le Gras S; Cormont M; Ballotti R; Bertolotto C; Davidson I
    Oncogene; 2011 May; 30(20):2319-32. PubMed ID: 21258399
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation.
    Larue L; Dougherty N; Porter S; Mintz B
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7816-20. PubMed ID: 1380168
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of S628N: a novel KIT mutation found in a metastatic melanoma.
    Vita M; Tisserand JC; Chauvot de Beauchêne I; Panel N; Tchertanov L; Agopian J; Mescam-Mancini L; Fouet B; Fournier B; Dubreuil P; Bertucci F; De Sepulveda P
    JAMA Dermatol; 2014 Dec; 150(12):1345-9. PubMed ID: 25317746
    [TBL] [Abstract][Full Text] [Related]  

  • 65. microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells.
    Arts N; Cané S; Hennequart M; Lamy J; Bommer G; Van den Eynde B; De Plaen E
    PLoS One; 2015; 10(4):e0122517. PubMed ID: 25853464
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma.
    Liang R; Wallace AR; Schadendorf D; Rubin BP
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):714-23. PubMed ID: 21595858
    [TBL] [Abstract][Full Text] [Related]  

  • 67. KIT in melanoma: many shades of gray.
    Slipicevic A; Herlyn M
    J Invest Dermatol; 2015 Feb; 135(2):337-338. PubMed ID: 25573046
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.
    Thurber AE; Douglas G; Sturm EC; Zabierowski SE; Smit DJ; Ramakrishnan SN; Hacker E; Leonard JH; Herlyn M; Sturm RA
    Oncogene; 2011 Jul; 30(27):3036-48. PubMed ID: 21358674
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF.
    Borgdorff V; Rix U; Winter GE; Gridling M; Müller AC; Breitwieser FP; Wagner C; Colinge J; Bennett KL; Superti-Furga G; Wagner SN
    Oncogene; 2014 May; 33(19):2531-9. PubMed ID: 23728343
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes.
    Lavelle TJ; Alver TN; Heintz KM; Wernhoff P; Nygaard V; Nakken S; Øy GF; Bøe SL; Urbanucci A; Hovig E
    Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32605315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma.
    Rivera RS; Nagatsuka H; Gunduz M; Cengiz B; Gunduz E; Siar CH; Tsujigiwa H; Tamamura R; Han KN; Nagai N
    Virchows Arch; 2008 Jan; 452(1):27-32. PubMed ID: 18066592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of MITF phosphorylation sites during coat color and eye development in mice analyzed by bacterial artificial chromosome transgene rescue.
    Bauer GL; Praetorius C; Bergsteinsdóttir K; Hallsson JH; Gísladóttir BK; Schepsky A; Swing DA; O'Sullivan TN; Arnheiter H; Bismuth K; Debbache J; Fletcher C; Warming S; Copeland NG; Jenkins NA; Steingrímsson E
    Genetics; 2009 Oct; 183(2):581-94. PubMed ID: 19635938
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Accumulating mutations in series of haplotypes at the KIT and MITF loci are major determinants of white markings in Franches-Montagnes horses.
    Haase B; Signer-Hasler H; Binns MM; Obexer-Ruff G; Hauswirth R; Bellone RR; Burger D; Rieder S; Wade CM; Leeb T
    PLoS One; 2013; 8(9):e75071. PubMed ID: 24098679
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anorectal melanoma with a KIT-activating mutation, which is a target for tyrosine kinase inhibitor.
    Itoh M; Goto A; Wakasugi H; Yoshida Y; Matsunaga Y; Fujii K; Suzuki K; Yonezawa K; Abe T; Arimura Y; Shinomura Y
    Int J Clin Oncol; 2011 Aug; 16(4):428-34. PubMed ID: 21069551
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor.
    Natali PG; Nicotra MR; Winkler AB; Cavaliere R; Bigotti A; Ullrich A
    Int J Cancer; 1992 Sep; 52(2):197-201. PubMed ID: 1381702
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genomic analysis reveals the association of KIT and MITF variants with the white spotting in swamp buffaloes.
    Dai D; Sari EM; Si J; Ashari H; Dagong MIA; Pauciullo A; Lenstra JA; Han J; Zhang Y
    BMC Genomics; 2024 Jul; 25(1):713. PubMed ID: 39048931
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
    Bertolotto C; Lesueur F; Giuliano S; Strub T; de Lichy M; Bille K; Dessen P; d'Hayer B; Mohamdi H; Remenieras A; Maubec E; de la Fouchardière A; Molinié V; Vabres P; Dalle S; Poulalhon N; Martin-Denavit T; Thomas L; Andry-Benzaquen P; Dupin N; Boitier F; Rossi A; Perrot JL; Labeille B; Robert C; Escudier B; Caron O; Brugières L; Saule S; Gardie B; Gad S; Richard S; Couturier J; Teh BT; Ghiorzo P; Pastorino L; Puig S; Badenas C; Olsson H; Ingvar C; Rouleau E; Lidereau R; Bahadoran P; Vielh P; Corda E; Blanché H; Zelenika D; Galan P; ; Aubin F; Bachollet B; Becuwe C; Berthet P; Bignon YJ; Bonadona V; Bonafe JL; Bonnet-Dupeyron MN; Cambazard F; Chevrant-Breton J; Coupier I; Dalac S; Demange L; d'Incan M; Dugast C; Faivre L; Vincent-Fétita L; Gauthier-Villars M; Gilbert B; Grange F; Grob JJ; Humbert P; Janin N; Joly P; Kerob D; Lasset C; Leroux D; Levang J; Limacher JM; Livideanu C; Longy M; Lortholary A; Stoppa-Lyonnet D; Mansard S; Mansuy L; Marrou K; Matéus C; Maugard C; Meyer N; Nogues C; Souteyrand P; Venat-Bouvet L; Zattara H; Chaudru V; Lenoir GM; Lathrop M; Davidson I; Avril MF; Demenais F; Ballotti R; Bressac-de Paillerets B
    Nature; 2011 Oct; 480(7375):94-8. PubMed ID: 22012259
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Review of the Aetiopathogenesis and Clinical and Histopathological Features of Oral Mucosal Melanoma.
    Feller L; Khammissa RAG; Lemmer J
    ScientificWorldJournal; 2017; 2017():9189812. PubMed ID: 28638859
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A novel mouse model demonstrates that oncogenic melanocyte stem cells engender melanoma resembling human disease.
    Sun Q; Lee W; Mohri Y; Takeo M; Lim CH; Xu X; Myung P; Atit RP; Taketo MM; Moubarak RS; Schober M; Osman I; Gay DL; Saur D; Nishimura EK; Ito M
    Nat Commun; 2019 Nov; 10(1):5023. PubMed ID: 31685822
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dedifferentiation of human epidermal melanocytes in vitro by long-term trypsinization.
    Chen RH; Xiao L; Zhang RZ; Wang SY; Li Y
    Cell Tissue Bank; 2021 Mar; 22(1):67-75. PubMed ID: 32978700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.